Incyte
INCY
#1110
Rank
C$27.80 B
Marketcap
C$141.63
Share price
2.05%
Change (1 day)
34.82%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): C$2.21 Billion

According to Incyte's latest financial reports the company's current earnings are C$4.81 Billion. In 2024 the company made an earning of C$0.43 Billion a decrease over its 2023 earnings that were of C$1.15 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$2.21 B407.05%
2024 C$0.43 B-62.04%
2023 C$1.15 B57.66%
2022 C$0.73 B-7.24%
2021 C$0.78 B-345.65%
2020 -C$0.33 Billion-147.7%
2019 C$0.67 B322.02%
2018 C$0.15 B-136.94%
2017 -C$0.44 Billion-390.76%
2016 C$0.14 B1322%
2015 C$10.43 M-115.56%
2014 -C$67.07 Million-41.4%
2013 -C$0.12 Billion87.67%
2012 -C$60.99 Million-74.9%
2011 -C$0.25 Billion843.59%
2010 -C$25.75 Million-88.68%
2009 -C$0.23 Billion1.37%
2008 -C$0.23 Billion86.16%
2007 -C$0.13 Billion17.64%
2006 -C$0.11 Billion-28.62%
2005 -C$0.15 Billion-36.1%
2004 -C$0.23 Billion-2.03%
2003 -C$0.23 Billion22.26%
2002 -C$0.19 Billion-27.39%
2001 -C$0.26 Billion198.72%
2000 -C$86.47 Million132.2%
1999 -C$37.24 Million-556.86%
1998 C$8.15 M-37.23%
1997 C$12.98 M-259.32%
1996 -C$8.16 Million-45.87%
1995 -C$15.06 Million-9.17%
1994 -C$16.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.38 B 419.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$92.27 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.08 B 1,316.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.37 B 646.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-C$63.45 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$76.75 Million-103.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.68 B 933.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
-C$40.12 Million-101.83%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$95.66 Million-104.36%๐Ÿ‡บ๐Ÿ‡ธ USA